|
|
Post by mango on Apr 27, 2018 14:14:47 GMT -5
New International MannKind Granted Patent Application Date: 23.06.2016 Publication Date: 29.03.2018 Grant Date: 29.03.2018 Applicants: MANNKIND CORPORATION CHAD C. SMUTNEY P. SPENCER KINSEY JOHN M. POLIDORO CARL R. SAHI SCOTT MCLEAN DENNIS OVERFIELD ANTHONY BRYANT TOM HE ALFRED MANN BENOIT ADAMO Inventors:CHAD C. SMUTNEY P. SPENCER KINSEY JOHN M. POLIDORO CARL R. SAHI SCOTT MCLEAN DENNIS OVERFIELD ANTHONY BRYANT TOM HE ALFRED MANN BENOIT ADAMO Title: (HE) מחסנית לתרופה בצורה של אבקה יבשה עבור משאף (Stack the medicine in the form of dry powder for the inhaler?) patentscope.wipo.int/search/en/detail.jsf?docId=IL214952836 |
|
|
|
Post by peppy on Apr 27, 2018 14:20:11 GMT -5
New International MannKind Granted Patent Application Date: 23.06.2016 Publication Date: 29.03.2018 Grant Date: 29.03.2018 Applicants: MANNKIND CORPORATION CHAD C. SMUTNEY P. SPENCER KINSEY JOHN M. POLIDORO CARL R. SAHI SCOTT MCLEAN DENNIS OVERFIELD ANTHONY BRYANT TOM HE ALFRED MANN BENOIT ADAMO Inventors:CHAD C. SMUTNEY P. SPENCER KINSEY JOHN M. POLIDORO CARL R. SAHI SCOTT MCLEAN DENNIS OVERFIELD ANTHONY BRYANT TOM HE ALFRED MANN BENOIT ADAMO Title: (HE) מחסנית לתרופה בצורה של אבקה יבשה עבור משאף (Stack the medicine in the form of dry powder for the inhaler?) patentscope.wipo.int/search/en/detail.jsf?docId=IL214952836Hebrew, Israel. Israel could use an inhaler. The Scientist (2015) Medical Marijuana: Studying For a Higher Purpose - Prof. Dr. Raphael Mechoulam www.youtube.com/watch?v=fu6FhJIyTEc |
|
|
|
Post by mytakeonit on Apr 27, 2018 17:34:48 GMT -5
WOW ... that is a fabulous video !!! One side effect that I noticed was that I kept reading the english translations ... even though they were speaking english. And, sometimes I wouldn't read the translation when they were speaking in a different language. AND, I was understanding them!  What is THE answer to that ... is the THC cure all. What? |
|
|
|
Post by mango on May 30, 2018 17:17:09 GMT -5
New MannKind Granted Patent 5/29/2018 Apparatus, system and method for measuring resistance of an inhalerAbstract: An apparatus, a closed-loop system and method for measuring the resistance of inhalation systems and/or devices are disclosed. Type: Grant Filed: November 5, 2014 Date of Patent: May 29, 2018 Assignee: MannKind Corporation Inventors: Benoit Adamo, Scott McLean, Chad C. Smutney, John M. Polidoro, Carl R. Sahi patents.justia.com/patent/9983108 |
|
|
|
Post by peppy on May 30, 2018 17:27:05 GMT -5
New MannKind Granted Patent 5/29/2018 Apparatus, system and method for measuring resistance of an inhalerAbstract: An apparatus, a closed-loop system and method for measuring the resistance of inhalation systems and/or devices are disclosed. Type: Grant Filed: November 5, 2014 Date of Patent: May 29, 2018 Assignee: MannKind Corporation Inventors: Benoit Adamo, Scott McLean, Chad C. Smutney, John M. Polidoro, Carl R. Sahi patents.justia.com/patent/9983108bluhale  |
|
|
|
Post by bioexec25 on May 30, 2018 17:40:55 GMT -5
At the recent ASM, I was able to speak with the team and test out the Bluhale with the newest phone app. Seemed to work great. I would vary the strength and time of the inhale and see the results in real time on the phone app. That conference room was shared by the bluhale and digital marketing teams. The DM team were discussing social media, analytics on the existing websites, optimized and paid search efforts. Was my favorite room at the meeting to be honest. :-))
|
|
|
|
Post by mango on May 30, 2018 17:45:25 GMT -5
At the recent ASM, I was able to speak with the team and test out the Bluhale with the newest phone app. Seemed to work great. I would vary the strength and time of the inhale and see the results in real time on the phone app. That conference room was shared by the bluhale and digital marketing teams. The DM team were discussing social media, analytics on the existing websites, optimized and paid search efforts. Was my favorite room at the meeting to be honest. :-)) That sounds awesome. What is the app called? |
|
|
|
Post by bioexec25 on May 30, 2018 18:14:37 GMT -5
At the recent ASM, I was able to speak with the team and test out the Bluhale with the newest phone app. Seemed to work great. I would vary the strength and time of the inhale and see the results in real time on the phone app. That conference room was shared by the bluhale and digital marketing teams. The DM team were discussing social media, analytics on the existing websites, optimized and paid search efforts. Was my favorite room at the meeting to be honest. :-)) That sounds awesome. What is the app called?
From a recent article by Mike Hoskins in March 2018 on Healthline: "MannKind has a training pilot program in place now, with a few sales reps taking the adapters into clinics for doctors to have their patients try out. Currently it's just an 8 to 10-week program that's starting out small, but Castagna hopes to bring more providers into the program before long. As BluHale's currently an adapter, the company is also exploring whether it could build the connectivity into the base inhaler itself, or whether it's best to keep the inhaler and BluHale accessory separate. Manufacturing, access and affordability all play into that decision. Eventually, Castagna's vision for this BluHale tech -- especially if they're able to add fiber-optics recognition -- would be to enable full Afrezza dose tracking and recognition of the color of a cartridge to know which are being used more, and data integration with existing apps and platforms. That is, MannKind does not intend to create their own mobile app or platform for Afrezza users, but instead wants to work within the D-Community so that Afrezza data becomes sharable via other platforms and apps. Castagna would like to see a day where an Afrezza inhaler icon could appear on a Dexcom CGM app, for example instead of just an injection icon as exists now".
www.healthline.com/diabetesmine/bluhale-tech-and-afrezza#1
|
|
|
|
Post by dreamboatcruise on May 30, 2018 19:51:16 GMT -5
That sounds awesome. What is the app called?
From a recent article by Mike Hoskins in March 2018 on Healthline: "MannKind has a training pilot program in place now, with a few sales reps taking the adapters into clinics for doctors to have their patients try out. Currently it's just an 8 to 10-week program that's starting out small, but Castagna hopes to bring more providers into the program before long. As BluHale's currently an adapter, the company is also exploring whether it could build the connectivity into the base inhaler itself, or whether it's best to keep the inhaler and BluHale accessory separate. Manufacturing, access and affordability all play into that decision. Eventually, Castagna's vision for this BluHale tech -- especially if they're able to add fiber-optics recognition -- would be to enable full Afrezza dose tracking and recognition of the color of a cartridge to know which are being used more, and data integration with existing apps and platforms. That is, MannKind does not intend to create their own mobile app or platform for Afrezza users, but instead wants to work within the D-Community so that Afrezza data becomes sharable via other platforms and apps. Castagna would like to see a day where an Afrezza inhaler icon could appear on a Dexcom CGM app, for example instead of just an injection icon as exists now".
www.healthline.com/diabetesmine/bluhale-tech-and-afrezza#1
That would take a programmer a half an hour to do at Dexcom. Though I guess if they made the icon look like the dreamboat there would be 2 weeks worth of legal work  I think there are third party devices to automatically log injections into apps as is contemplated for the dreamboat here, but I don't think they are widely used. Doesn't seem a very big deal to press a couple of buttons to log an insulin dose. If one really wants useful info, they are already needing to open the app to log food consumption... unless Mannkind can modify the acoustic technology to recognize the sound of chewing and log the type and quantity of food. |
|
|
|
Post by bioexec25 on May 30, 2018 20:14:13 GMT -5
DBC I think he was referring to an effort to agree a collaboration to show alignment with inhaled insulin. Sure that icon effort programmatically isn’t hard. Now the other mods for auto sensing dosing units and tying that data stream to multi-platform inhalation analytics is not a simple programmer exercise. It’s quite complicated.
|
|
|
|
Post by dreamboatcruise on May 30, 2018 22:10:36 GMT -5
DBC I think he was referring to an effort to agree a collaboration to show alignment with inhaled insulin. Sure that icon effort programmatically isn’t hard. Now the other mods for auto sensing dosing units and tying that data stream to multi-platform inhalation analytics is not a simple programmer exercise. It’s quite complicated. I always thought MNKD had proven with trials that a reliable dose of Afrezza is delivered over a very broad range of respiratory force. What sort of inhalation analytics do you imagine would have use? Seems the current Bluhale could have use in doc office, just to verify someone takes a puff correctly. But hopefully it isn't complicated enough to do so that patients need constant monitoring. I've never used it, but from what I see users saying, it is pretty simple. My point was that users of injections seem to be fine with entering a dose manually in their CGM (or other diabetes) app, so why would Afrezza seem to need some sort of complicated/expenses gadgetry |
|
|
|
Post by uvula on May 31, 2018 5:58:46 GMT -5
If bluhale cannot detect the cartridge size it cannot automatically tell a cgm how much afrezza was inhaled. I'm also confused about why bluhale is so important. If you inhale and the cartridge has no powder left in it then it is probably in your lungs.
Having said that, I'm sure bluhale is important. I just don't understand why.
|
|
|
|
Post by sportsrancho on May 31, 2018 6:15:42 GMT -5
|
|
|
|
Post by dh4mizzou on May 31, 2018 6:28:29 GMT -5
DBC I think he was referring to an effort to agree a collaboration to show alignment with inhaled insulin. Sure that icon effort programmatically isn’t hard. Now the other mods for auto sensing dosing units and tying that data stream to multi-platform inhalation analytics is not a simple programmer exercise. It’s quite complicated. I always thought MNKD had proven with trials that a reliable dose of Afrezza is delivered over a very broad range of respiratory force. What sort of inhalation analytics do you imagine would have use? Seems the current Bluhale could have use in doc office, just to verify someone takes a puff correctly. But hopefully it isn't complicated enough to do so that patients need constant monitoring. I've never used it, but from what I see users saying, it is pretty simple. My point was that users of injections seem to be fine with entering a dose manually in their CGM (or other diabetes) app, so why would Afrezza seem to need some sort of complicated/expenses gadgetry DBC,
It seems like all of this would fall into the willing laps of the Millennials who can't do ANYTHING without it involving their phones.
|
|
|
|
Post by dreamboatcruise on May 31, 2018 10:14:02 GMT -5
I always thought MNKD had proven with trials that a reliable dose of Afrezza is delivered over a very broad range of respiratory force. What sort of inhalation analytics do you imagine would have use? Seems the current Bluhale could have use in doc office, just to verify someone takes a puff correctly. But hopefully it isn't complicated enough to do so that patients need constant monitoring. I've never used it, but from what I see users saying, it is pretty simple. My point was that users of injections seem to be fine with entering a dose manually in their CGM (or other diabetes) app, so why would Afrezza seem to need some sort of complicated/expenses gadgetry DBC,
It seems like all of this would fall into the willing laps of the Millennials who can't do ANYTHING without it involving their phones.
Hopefully they do some market research on how well the 3rd party devices for pens are selling. I've still not seen/heard of anyone, millennial or otherwise, using one. Also, not hearing about Lilly, Novo or Sanofi planning to add bluetooth connectivity. To me it just seems like an unnecessary manufacturing expense. Even if someone wishes to track things on their phone, and in this case there may be valid reason for people of all ages to do so, if you need to open the app and hit a button to log a meal anyway it seems hitting another button to indicate which cartridge of Afrezza isn't something even a young person would mind doing. Another case in point is quite a few companies developed bluetooth enabled caps for pill bottles or smart pill cases... do you know of any millennials using those? Actually the intended market was the elderly, but I don't even think they caught on at all. Maybe it's just a misconception that there is an automatic market for any and everything to be connected. [Edit:] Here is an article on what looks like one of the more sophisticated bluetooth connected pill bottles. I like the industrial design. Never seen anyone using a bluetooth/WiFi connected one. www.npr.org/sections/health-shots/2017/08/22/538153337/smart-pill-bottles-arent-enough-to-help-the-medicine-go-down |
|
What is THE answer to that ... is the THC cure all.
